Journal
CURRENT OPINION IN PLANT BIOLOGY
Volume 7, Issue 2, Pages 159-165Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.pbi.2004.01.012
Keywords
-
Categories
Funding
- NIGMS NIH HHS [R01GM54659] Funding Source: Medline
Ask authors/readers for more resources
Protein-based therapeutics have enjoyed great success over the past decade. Unfortunately, this clinical success has come with a heavy price tag that is due to the inherently high costs of the capitalization and production of these complex molecules using current mammalian-based fermentation systems. Recent progress has been made in the production of recombinant proteins, including antibodies, in the eukaryotic unicellular green alga Chlamydomonas reinhardtii. C. reinhardtii offers an attractive alternative to traditional mammalian-based expression systems for several reasons, including its ability to provide stable plastid and nuclear transformants rapidly and its inherently low costs for capitalization and production.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available